Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 3 (2006), Issue 8 (August)

1. Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study.
   Am J Clin Oncol, 29(4): 345-51. [Abstract] [Full-text]
2. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
   Am J Clin Oncol, 29(4): 328-35. [Abstract] [Full-text]
3. 8-Chloro-adenosine inhibits growth at least partly by interfering with actin polymerization in cultured human lung cancer cells.
   Biochem Pharmacol, 72(5): 541-50. [Abstract] [Full-text]
4. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
   Cancer Chemother Pharmacol, 58(5): 601-6. [Abstract] [Full-text]
5. Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer.
   Cancer Immunol Immunother, 55(11): 1320-9. [Abstract] [Full-text]
6. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
   N Engl J Med, 355(6): 570-80. [Abstract] [Full-text]
7. Design of 4D treatment planning target volumes.
   Int J Radiat Oncol Biol Phys, 66(1): 287-95. [Abstract] [Full-text]
8. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
   Int J Radiat Oncol Biol Phys, 66(1): 126-34. [Abstract] [Full-text]
9. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
   Int J Radiat Oncol Biol Phys, 66(1): 108-16. [Abstract] [Full-text]
10. Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect?
    Int J Radiat Oncol Biol Phys, 66(1): 135-41. [Abstract] [Full-text]
11. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.
    Int J Radiat Oncol Biol Phys, 66(1): 100-7. [Abstract] [Full-text]
12. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 66(1): 117-25. [Abstract] [Full-text]
13. Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).
    Br J Cancer, 95(4): 470-4. [Abstract] [Full-text]
14. Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort study.
    BMJ, 333(7564): 376. [Abstract] [Full-text]
15. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
    J Clin Oncol, 24(24): 3831-7. [Abstract] [Full-text]
16. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    J Clin Oncol, 24(24): 3823-30. [Abstract] [Full-text]
17. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer.
    Int J Cancer, 119(6): 1419-26. [Abstract] [Full-text]
18. Frequent EGFR mutations in brain metastases of lung adenocarcinoma.
    Int J Cancer, 119(6): 1491-4. [Abstract] [Full-text]
19. Radon, secondhand smoke, glutathione-S-transferase M1 and lung cancer among women.
    Int J Cancer, 119(6): 1462-7. [Abstract] [Full-text]
20. Modified approach of administering cytostatics to the lung: more efficient isolated lung perfusion.
    Ann Thorac Surg, 82(3): 1033-7. [Abstract] [Full-text]
21. Lung cancer surgery in patients with liver cirrhosis.
    Ann Thorac Surg, 82(3): 1027-32. [Abstract] [Full-text]
22. Video-assisted thoracoscopic surgery lobectomy for c-T1N0M0 primary lung cancer: its impact on locoregional control.
    Ann Thorac Surg, 82(3): 1021-6. [Abstract] [Full-text]
23. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Ann Thorac Surg, 82(3): 1016-20. [Abstract] [Full-text]
24. Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer.
    Ann Thorac Surg, 82(3): 1009-15; discussion 1015. [Abstract] [Full-text]
25. NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells.
    Int J Cancer, 119(7): 1547-52. [Abstract] [Full-text]
26. Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells.
    Exp Cell Res, 312(15): 2806-15. [Abstract] [Full-text]
27. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
    BMC Cancer, 6: 203. [Abstract] [Full-text]
28. Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspiration.
    Cancer, 108(4): 206-11. [Abstract] [Full-text]
29. Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis.
    Am J Clin Pathol, 126(4): 608-15. [Abstract] [Full-text]
30. Present and future of lung cancer vaccines.
    Expert Opin Emerg Drugs, 11(3): 445-59. [Abstract] [Full-text]
31. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.
    Cancer, 107(5): 1042-9. [Abstract] [Full-text]
32. Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer.
    Cancer, 107(5): 1050-4. [Abstract] [Full-text]
33. A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer.
    Cancer, 107(5): 1034-41. [Abstract] [Full-text]
34. CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer.
    Int J Cancer, 119(8): 1819-28. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.